Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study

PURPOSE: We evaluated the novel combination of aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting (rinv) among patients receiving moderately-emetogenic radiotherapy for thoracolumbar bone metastases. METHODS: In this single-centre two-arm nonrandomized prospec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Oncol
Autors principals: Dennis, K., De Angelis, C., Jon, F., Lauzon, N., Pasetka, M., Holden, L., Barnes, E., Danjoux, C., Sahgal, A., Tsao, M., Chow, E.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257120/
https://ncbi.nlm.nih.gov/pubmed/25489264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.2051
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars